tolbutamide has been researched along with trypan blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kawamura, H; Kodama, T; Oku, H; Puro, DG; Sakagami, K | 1 |
2 other study(ies) available for tolbutamide and trypan blue
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Platelet-derived growth factor-BB: a survival factor for the retinal microvasculature during periods of metabolic compromise.
Topics: Adenosine Triphosphate; Animals; Antimycin A; Becaplermin; Capillaries; Cell Survival; Iodoacetates; Ischemia; Platelet-Derived Growth Factor; Potassium Channels; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Retinal Diseases; Retinal Vessels; Tolbutamide; Trypan Blue | 2001 |